The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 24, Issue 2, Pages 213-223
Publisher
Springer Nature
Online
2018-01-02
DOI
10.1038/nm.4461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis
- (2017) Feng-Juan Yan et al. HEPATOLOGY
- USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity
- (2017) Shimin An et al. HEPATOLOGY
- Therapies in non-alcoholic steatohepatitis (NASH)
- (2017) Abdul M. Oseini et al. LIVER INTERNATIONAL
- Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
- (2017) Pi-Xiao Wang et al. NATURE MEDICINE
- Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
- (2017) Guang-Nian Zhao et al. NATURE MEDICINE
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
- (2016) Joel T. Haas et al. Annual Review of Physiology
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis
- (2016) Ling Gao et al. JOURNAL OF HEPATOLOGY
- Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
- (2016) Mei Xiang et al. JOURNAL OF HEPATOLOGY
- Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury
- (2016) Junfei Hu et al. JOURNAL OF HEPATOLOGY
- Cylindromatosis-A Protective Molecule against Liver Diseases
- (2016) Claus Hellerbrand et al. MEDICINAL RESEARCH REVIEWS
- Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
- (2016) Pi-Xiao Wang et al. Nature Communications
- The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
- (2016) Yan-Xiao Ji et al. Nature Communications
- CYLD-Mediated Signaling and Diseases
- (2015) Bryan Mathis et al. CURRENT DRUG TARGETS
- The deubiquitinating enzyme CYLD regulates the differentiation and maturation of thymic medullary epithelial cells
- (2015) Sonja Reissig et al. IMMUNOLOGY AND CELL BIOLOGY
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis
- (2015) Yongge Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Deubiquitinase CYLD acts as a negative regulator for bacterium NTHi-induced inflammation by suppressing K63-linked ubiquitination of MyD88
- (2015) Byung-Cheol Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nonalcoholic Steatohepatitis: A Search for Factual Animal Models
- (2015) Sheila Cristina L. Sanches et al. Biomed Research International
- Truncation of the Catalytic Domain of the Cylindromatosis Tumor Suppressor Impairs Lung Maturation
- (2015) Eirini Trompouki et al. NEOPLASIA
- TAK1 control of cell death
- (2014) S R Mihaly et al. CELL DEATH AND DIFFERENTIATION
- TAK1 regulates hepatic cell survival and carcinogenesis
- (2014) Yoon Seok Roh et al. JOURNAL OF GASTROENTEROLOGY
- MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
- (2014) Na Zhao et al. Molecular Cancer
- Ubiquitination in disease pathogenesis and treatment
- (2014) Doris Popovic et al. NATURE MEDICINE
- TRAF1 is a key mediator for hepatic ischemia/reperfusion injury
- (2014) X-F Zhang et al. Cell Death & Disease
- Transforming Growth Factor–β Signaling in Hepatocytes Promotes Hepatic Fibrosis and Carcinogenesis in Mice With Hepatocyte-Specific Deletion of TAK1
- (2013) Ling Yang et al. GASTROENTEROLOGY
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Cell type-specific function of TAK1 in innate immune signaling
- (2013) Adebusola A. Ajibade et al. TRENDS IN IMMUNOLOGY
- Inactivation of the Deubiquitinase CYLD in Hepatocytes Causes Apoptosis, Inflammation, Fibrosis, and Cancer
- (2012) Kostas Nikolaou et al. CANCER CELL
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
- (2012) Anurag Singh et al. CELL
- TAK1, more than just innate immunity
- (2012) Liang Dai et al. IUBMB LIFE
- Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice
- (2012) Toni Urbanik et al. JOURNAL OF HEPATOLOGY
- The Tumor Suppressor CYLD Controls the Function of Murine Regulatory T Cells
- (2012) S. Reissig et al. JOURNAL OF IMMUNOLOGY
- CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt
- (2012) Jae Hyang Lim et al. Nature Communications
- Thymocyte-Specific Truncation of the Deubiquitinating Domain of CYLD Impairs Positive Selection in a NF- B Essential Modulator-Dependent Manner
- (2010) A. Tsagaratou et al. JOURNAL OF IMMUNOLOGY
- Ubiquitin chain cleavage: CYLD at work
- (2010) Ramin Massoumi TRENDS IN BIOCHEMICAL SCIENCES
- Phosphorylation of the Tumor Suppressor CYLD by the Breast Cancer Oncogene IKKɛ Promotes Cell Transformation
- (2009) Jessica E. Hutti et al. MOLECULAR CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started